Germany’s BLUU Seafood is a food biotech which is cultivating fish cells to produce fish products - leaving the actual live fish to go about their day, living their best fish lives, and not ending up on a plate somewhere. It is creating hybrid products, such as fish balls and fish fingers, which are blended with plant-based proteins.
The company has just raised a €16 million Series A round which will help it ‘push for regulatory approval' of its products and 'deepen research and development, and initiate pilot production in Hamburg'. BLUU Seafood has plans for market entry in Singapore by 2024 - where the sale of cultivated chicken has already been approved by regulators in 2020.
The round was led by Sparkfood and LBBW VC and includes SeaX Ventures, Manta Ray Ventures, Norrsken VC, Delivery Hero, Innovationsstarter Fonds Hamburg GmbH and Dr. Oetker.
"Our successful Series-A demonstrates the enormous potential that lies in cultivated fish as a platform technology for sustainable animal protein and underlines the strong scientific development that we at BLUU Seafood have delivered so far. Together with our strong, international investor base, we can start the next stage of development and bring our first products to market,” says Dr. Sebastian Rakers, co-founder and CEO of BLUU Seafood.
Main Image: BlUU Seafood co-founder Simon Fabich (MD) and Dr Sebastian Rakers (CEO), Cheif Operating Officer Dr Christian Dammann. Source: Bluu GmbH H. Gergen
Fish Balls Image copyright Bluu GmbH Wim Jansen
Would you like to write the first comment?
Login to post comments